Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...

Psychosis and schizophrenia are related but distinct mental health conditions characterized by distorted thoughts, perceptions, and a sense of reality. Psychosis describes this specific collection ...

More information: Chin Wen Png et al, DUSP6 regulates Notch1 signalling in colorectal cancer, Nature Communications (2024). DOI: 10.1038/s41467-024-54383-y ...

One of them was on his phone. At 44, I like to think I’m aging gracefully with schizophrenia. I know not to react to a feeling I cannot explain. As the two men entered the restaurant ...

The failure of Cerevel's emraclidine in schizophrenia will cost AbbVie an impairment charge of about $3.5 billion, the pharma said in a Jan. 10 filing with the Securities and Exchange Commission.

I politely got off the phone and then yelled in frustration. Over the next year his diagnosis was confirmed: schizophrenia. Tim started medication, which helped for a while. He was never quite ...